Thailand PM to open international symposium in Bangkok on stem cell therapy for the failing heart November 27, 2006

Posted by TheraVitae in : VesCell in the News , trackback

Summary: Bangkok Heart Hospital and TheraVitae are to co-sponsor a symposium December 1-3 at the Inter-Continental Hotel, Bangkok. Eminent researchers, heart specialists and biotechnology industry leaders from many countries will present the successes and challenges of treating patients with advanced heart diseases using stem cells.

BANGKOK, Thailand, 27 November 2006 – Delegates from around the world will join leading scientists and researchers, medical specialists and industry leaders at a stem cell therapy symposium in Bangkok December 1-3, 2006.

The Prime Minister of Thailand, General Surayud Chulanont, will open the three-day event which has been organized to provide a forum where the latest clinical techniques and current research can be discussed. This will facilitate better insight into the emerging technologies and techniques of helping those who suffer from cardiac disease.

President of TheraVitae, Thailand, Mr. Narin Apichairak, said: “We are honored and excited to be a co-sponsor of this event. We are at the dawn of a new era in medicine and it is essential that both healthcare providers and the public understand the true benefits of stem cells.”

“I’m delighted to have such positive support from the Thai Government as well as prominent people from within the industry. With the governments’ support, Thailand is poised to become a major international player in the field of regenerative medicine.”

Interested parties can view the full details of the symposium on www.stemcellbangkok.com
Contact: Jon Bradshaw
Theravitae Co., Ltd.
36/72 PS Tower, 21/Fl., Sukhumvit 21
Klongtoey Nua, Bangkok 10110
Phone: +662.664.4290
Fax: +662.664.4289
Mobile: +668.1987.8197

History: TheraVitae is a multi-national biotechnology company and is the researcher and developer of VesCell™. It is treating Cardiac & PAD patients using adult stem cell therapy, safely and effectively, in Bangkok and Singapore.